Collaborator Overview

The DetectCID Consortium comprises research programs at the Albert Einstein College of Medicine, Northwestern University, and the University of California, San Francisco. 

Albert Einstein College of Medicine

Led by Dr. Joe Verghese, the DetectCID team at Albert Einstein College of Medicine has developed the 5-Cog Battery to improve detection of cognitive impairment and dementia.

Northwestern University

Led by Drs. Richard Gershon and Michael Wolf, the DetectCID team at Northwestern University has developed the MyCog project, for the rapid detection of cognitive impairment in everyday clinical settings. 

University of California, San Francisco

Led by Dr. Katherine Possin, the DetectCID team at the University of California, San Francisco (UCSF) has developed the Brain Health Assessment for detecting and diagnosing neurocognitive disorders. UCSF also acts as the Cross-Consortium Coordinating Team (CCCT) of DetectCID. 

National Institutes of Neurological Disorders and Stroke

The National Institutes of Neurological Disorders and Stroke (NINDS) initiated the DetectCID consortium with the goal of developing simple, quick clinical paradigms to administer in a primary care clinical setting.